- Home
- GDEN vs IMTX Comparison
GDEN vs IMTX Comparison
Compare GDEN & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEN
- IMTX
- Stock Information
- Founded
- GDEN 1998
- IMTX N/A
- Country
- GDEN United States
- IMTX Germany
- Employees
- GDEN N/A
- IMTX N/A
- Industry
- GDEN Services-Misc. Amusement & Recreation
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GDEN Consumer Discretionary
- IMTX Health Care
- Exchange
- GDEN Nasdaq
- IMTX Nasdaq
- Market Cap
- GDEN 856.1M
- IMTX 954.2M
- IPO Year
- GDEN 1999
- IMTX N/A
- Fundamental
- Price
- GDEN $32.45
- IMTX $5.71
- Analyst Decision
- GDEN Strong Buy
- IMTX Strong Buy
- Analyst Count
- GDEN 7
- IMTX 4
- Target Price
- GDEN $36.57
- IMTX $16.67
- AVG Volume (30 Days)
- GDEN 134.0K
- IMTX 1.2M
- Earning Date
- GDEN 02-27-2025
- IMTX 03-20-2025
- Dividend Yield
- GDEN 3.10%
- IMTX N/A
- EPS Growth
- GDEN N/A
- IMTX N/A
- EPS
- GDEN 1.27
- IMTX N/A
- Revenue
- GDEN $733,305,000.00
- IMTX $128,824,447.00
- Revenue This Year
- GDEN N/A
- IMTX $116.22
- Revenue Next Year
- GDEN $2.03
- IMTX N/A
- P/E Ratio
- GDEN $25.45
- IMTX N/A
- Revenue Growth
- GDEN N/A
- IMTX 52.53
- 52 Week Low
- GDEN $27.42
- IMTX $5.20
- 52 Week High
- GDEN $39.92
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- GDEN 50.19
- IMTX 32.86
- Support Level
- GDEN $31.90
- IMTX $5.20
- Resistance Level
- GDEN $33.90
- IMTX $5.57
- Average True Range (ATR)
- GDEN 0.67
- IMTX 0.24
- MACD
- GDEN -0.03
- IMTX 0.05
- Stochastic Oscillator
- GDEN 39.83
- IMTX 30.88
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.